| dc.creator | Díaz-Peña R. | |
| dc.creator | Vidal-Castiñeira J.R. | |
| dc.creator | Mulero J. | |
| dc.creator | Sánchez A. | |
| dc.creator | Queiro R. | |
| dc.creator | López-Larrea C. | |
| dc.date.accessioned | 2020-09-02T22:16:52Z | |
| dc.date.accessioned | 2022-11-08T20:27:27Z | |
| dc.date.available | 2020-09-02T22:16:52Z | |
| dc.date.available | 2022-11-08T20:27:27Z | |
| dc.date.created | 2020-09-02T22:16:52Z | |
| dc.date.issued | 2015 | |
| dc.identifier | 180, 2, 201-206 | |
| dc.identifier | 00099104 | |
| dc.identifier | https://hdl.handle.net/20.500.12728/4363 | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5146452 | |
| dc.language | en | |
| dc.publisher | Blackwell Publishing Ltd | |
| dc.subject | Ankylosing spondylitis | |
| dc.subject | HLA-B27 | |
| dc.subject | KIR | |
| dc.subject | Susceptibility | |
| dc.subject | killer cell immunoglobulin like receptor | |
| dc.subject | killer cell immunoglobulin like receptor 2DL1 | |
| dc.subject | killer cell immunoglobulin like receptor 2DL2 | |
| dc.subject | killer cell immunoglobulin like receptor 2DL3 | |
| dc.subject | killer cell immunoglobulin like receptor 2DL4 | |
| dc.subject | killer cell immunoglobulin like receptor 2DL5 | |
| dc.subject | killer cell immunoglobulin like receptor 2DS1 | |
| dc.subject | killer cell immunoglobulin like receptor 2DS2 | |
| dc.subject | killer cell immunoglobulin like receptor 2DS3 | |
| dc.subject | killer cell immunoglobulin like receptor 2DS4 | |
| dc.subject | killer cell immunoglobulin like receptor 2DS5 | |
| dc.subject | killer cell immunoglobulin like receptor 3DL1 | |
| dc.subject | killer cell immunoglobulin like receptor 3DS1 | |
| dc.subject | unclassified drug | |
| dc.subject | HLA B27 antigen | |
| dc.subject | killer cell immunoglobulin like receptor | |
| dc.subject | killer cell immunoglobulin like receptor 3DS1 | |
| dc.subject | KIR2DS1 protein, human | |
| dc.subject | adult | |
| dc.subject | ankylosing spondylitis | |
| dc.subject | Article | |
| dc.subject | clinical feature | |
| dc.subject | controlled study | |
| dc.subject | disease predisposition | |
| dc.subject | gene frequency | |
| dc.subject | genetic association | |
| dc.subject | genetic predisposition | |
| dc.subject | genotype | |
| dc.subject | haplotype | |
| dc.subject | human | |
| dc.subject | immunopathogenesis | |
| dc.subject | major clinical study | |
| dc.subject | priority journal | |
| dc.subject | Spain | |
| dc.subject | ankylosing spondylitis | |
| dc.subject | clinical trial | |
| dc.subject | female | |
| dc.subject | gene frequency | |
| dc.subject | genetic predisposition | |
| dc.subject | genetics | |
| dc.subject | genotype | |
| dc.subject | genotyping technique | |
| dc.subject | immunology | |
| dc.subject | male | |
| dc.subject | multicenter study | |
| dc.subject | pathology | |
| dc.subject | Female | |
| dc.subject | Gene Frequency | |
| dc.subject | Genetic Predisposition to Disease | |
| dc.subject | Genotype | |
| dc.subject | Genotyping Techniques | |
| dc.subject | HLA-B27 Antigen | |
| dc.subject | Humans | |
| dc.subject | Male | |
| dc.subject | Receptors, KIR | |
| dc.subject | Receptors, KIR3DS1 | |
| dc.subject | Spondylitis, Ankylosing | |
| dc.title | Activating killer immunoglobulin-like receptors genes are associated with increased susceptibility to ankylosing spondylitis | |
| dc.type | Article | |